I think that you keep missing the point. Firstly, we are not looking at using MagSeinse for Her2 only. We are doing the first in human trials on Her2. Current plans are for use of the technology to also detect ovarian and prostate cancers. We are not saying that MagSense will replace biopsies. Our nanoparticles will only attach themselves to cancers and not benign tumors. We will do this in a radiation free environment and eliminate unnecessary surgical interventions. You can find all of this information on the company's website. Welcome on board. We are at a critical time in our journey and the next hurdle will be an absolute game changer win or lose. I'm in pretty deep on this one and it's exciting.
IBX Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
